Class IITerminatedD-1435-2019
Drug recall · June 19, 2019
Sevoflurane recall
Why: Failed Stability Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64
- Lots / codes
Lot #: S110F822 Exp. 5/31/2021
- Quantity
- 5940 bottles
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- Nationwide within the United States
- Initiated
- June 13, 2019 · Voluntary: Firm initiated
- Classified
- June 28, 2019
- Reported
- June 19, 2019
- Ended
- April 29, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sevoflurane
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.